Clinical Study

Non-Dialysis Dependent Chronic Kidney Disease Patients With Anemia Study, To Compare Vadadustat Anemia Pill With Standard Of Care Injections

Posted Date: May 15, 2019

  • Investigator: Shashi Kant
  • Type of Study: Drug

The study drug (vadadustat, also called AKB-6548) is an investigational drug. It will be referred to as the ?study drug? in this document, and any treatment in the study (including the study drug) may be referred to as ?study medication?. This potential new drug is being tested to treat anemia (low

Criteria:

Diagnosis Of Chronic Kidney Disease Egfr <=60, Screening Hgb <10 G/Dl, Adequate Iron Stores. Anemia

Keywords:

Anemia, Erythropoeisis Stimu, Chronic Kidney Disea

For More Information:

Karen Case, Ccrp
513-559-3367
karen.case@uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.